Syndax Pharmaceuticals Inc - SNDX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$2.386B
QoQ value delta ($000)
-$6.393M (-0.27%)
Implied price effect (QoQ)
-0.09%
Shares
Total shares
109,231,654
QoQ shares delta
-194,103 (-0.18%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SNDX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 30 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BlackRock, Inc. 197,177 9,020,006 0.0%
Kynam Capital Management, LP 175,993 8,050,959 9.73%
GOLDMAN SACHS GROUP INC 128,127 5,861,265 0.01%
STATE STREET CORP 123,693 5,658,424 0.0%
BANK OF AMERICA CORP /DE/ 88,425 4,045,094 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 85,863 3,927,892 0.0%
DEERFIELD MANAGEMENT COMPANY, L.P. 82,628 3,779,900 0.86%
Eversept Partners, LP 61,168 2,798,210 3.17%
GEODE CAPITAL MANAGEMENT, LLC 56,499 2,584,136 0.0%
Hood River Capital Management LLC 56,055 2,564,279 0.41%
KINGDON CAPITAL MANAGEMENT, L.L.C. 54,650 2,500,000 5.6%
FRANKLIN RESOURCES INC 49,982 2,286,499 0.01%
MILLENNIUM MANAGEMENT LLC 44,899 2,053,960 0.02%
VANGUARD PORTFOLIO MANAGEMENT LLC 42,010 1,921,796 0.0%
SILVERARC CAPITAL MANAGEMENT, LLC 41,708 1,907,990 4.33%
UBS Group AG 41,397 1,893,750 0.01%
Elmind Capital, LP 40,550 1,855,000 10.19%
BNP Paribas Asset Management Holding S.A. 39,133 1,790,173 0.04%
Candriam S.C.A. 37,039 1,696,040 0.17%
Soleus Capital Management, L.P. 35,588 1,628,039 1.23%
TWO SIGMA INVESTMENTS, LP 34,497 1,578,125 0.02%
ORBIMED ADVISORS LLC 33,708 1,542,000 0.62%
Nuveen, LLC 29,829 1,364,575 0.01%
MPM BioImpact LLC 29,150 1,333,523 1.78%
Aisling Capital Management LP 28,785 1,316,806 6.1%